Rigshospitalet, Denmark: Carcinoma trials

The registry lists 11 Carcinoma studies with Rigshospitalet, Denmark as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin AssessmentNot yet recruitingNCT05843032Not applicable
• Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationNCT05709171Phase 2
• Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationNCT05396118Phase 2
• Ex Vivo 3D-ultrasound for Oropharyngeal CancerCompletedNCT06314711Not applicable
• Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown PrimaryCompletedNCT05841966Not applicable
• Surgical Margin Assessment by 3D UltrasoundStatus unknownNCT05740774Not applicable
• Ablation of Hepatocellular Carcinoma: a Nationwide StudyCompletedNCT05498779
• Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSASCompletedNCT04189107Phase 3
• uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the LungStatus unknownNCT02755675Phase 2
• Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00351195Phase 2
• Trial With Taxotere and Cisplatin in Non-operable Adrenocortical CarcinomaCompletedNCT00324012Phase 2